SAA is a biomarker to distinguish the severity and prognosis of Coronavirus Disease 2019 (COVID-19)
countries. This new type of coronavirus could cause severe acute respiratory syndrome and injuries in other systems as well. The disease progresses rapidly, leading to multiple organ failure and death 1 2 . Quite a few patients have no specific symptoms/signs or radiological abnormalities at the early stage, with only mild symptoms, making the early diagnosis of disease difficult.
Therefore, early identification of the infection and creating effective treatment plan are particularly imperative 3 4 . A series of inflammation factors, such as serum amyloid A (SAA) 
Methods

Data sources
We conducted a retrospective study focusing on the significance of SAA in evaluating the We extracted the medical records of patients and sent these to the data collection center of 2) CT imaging classification: the imaging was classified into four types of normal, mild, progressive, and severe, with scored at 0, 1, 2, and 3, respectively.
(1) Mild: the main manifestations are ground-glass opacities and consolidation. Some cases show very thin, small patchy subpleural ground-glass opacities or ground-glass nodules. Lesions can be single or multiple, and both lung lobes can be involved. Lesions are more common in the middle and lower lobes, and mostly distributed in the outer zones of the lung and subpleural areas.
(2) Progressive: large lesions can be seen and multiple lung lobes in both lungs can be involved.
Consolidation and fibrosis of varying sizes are often seen within the lesions. Some cases may be accompanied by bronchial retraction, bronchiectasis, and interlobular pleural thickening.
However, pleural effusion and enlarged mediastinal lymph nodes are rare in this type.
(3) Severe: Lesions are diffuse in both lungs and uneven in density. Large areas of consolidation and ground-glass opacities can be seen. The sign of -white lung‖ can be seen due to large areas of the lung are involved. The interlobular pleura and bilateral pleura are usually thickened, and pleural effusion can be seen.
3) Outcome of illness: According to clinical progression, cases were divided into four types:
fully recovered, improved, exacerbation, and death.
Statistical methods
Statistical analysis was performed using SPSS 25.0 software. Kruskal-Wallis H-test and independent sample chi-square test were used to analyze differences between groups. Due to unequal variance, Tamhane 's T2 statistical method was a fair measure to perform multiple comparisons among groups of mild, moderate, severe, and critical severe patients for the value of SAA/L. Two-tailed P value less than 0.05 was considered statistically significant. The Receiver
Operating Characteristic curve (ROC curve) was used to calculate the area under the curve (AUC) of SAA, CRP, L, and SAA / L in order to evaluate the sensitivity and specificity of these factors. Spearman correlation coefficient was utilized to measure the degree of correlation between the hierarchically ordered variables in this study.
Patient and public involvement
This was a retrospective case series study and no patients were involved in the study design, setting the research questions, or the outcome measures directly. No patients were asked to advise on interpretation or writing up of results.
Results
Demographic characteristics
From January 18, 2020 to February 26, 2020, 693 patients with COVID-19 was treated in Tianyou Hospital, and 132 patients met the requirements of this study. The patients were between 33-89 years old, with an average age of 62 years. And 87 of 132 patients were over 60 years, accounting for 65.9%. Of these patients, 75 were males, accounting for 56.8%, and 57 were females, accounting for 43.2%. (table 1) At the time of admission, 60 patients had mild or moderate symptoms, accounting for 45.5%;
and 56 patients had severe symptoms, accounting for 42.4%. 16 of 132 patients were critically severe, accounting for 12.1%. In this study, more patients were male and more patients were more than 60 years, consistently with previous literature reports [3] . (table 1 According to the results showed in Table 2 , with disease progressing from mild to critically severe, SAA and CRP gradually increased, while L gradually decreased (P<0.05). However, PLT, WBC, and PCT were all within the normal ranges, suggesting that SAA, CRP, and L are closely related to disease classification, while WBC, PCT, and PLT are of little significance.
Due to unequal variance, Tamhane 's T2 statistical method was a fair measure to perform multiple comparisons among groups of mild, moderate, severe, and critical severe patients for the value of SAA/L. The SAA/L of severe/critically severe patients was significantly higher than that of mild/moderate ones, and p<0.01 indicates significant difference. (Fig 1) .
(3) SAA/L、CRP、SAA、L and clinical classification
To detect if SAA/L is more sensitive in predicting the severity of disease, the authors used ROC curve analysis to calculate the area under the curve (AUC), regarding mild/moderate type as negative whereas severe/critical severe type as positive. The results showed that AUC from high to low was SAA1/L1 > CRP1 > SAA1 > L1, with the specific value at 0.748, 0.744, 0.718, and 0.700, respectively. Next, the authors used the method of Jordan Index to calculate the critical values of SAA/L that could be utilized as the reference for patient clinical classification (Fig 2) .
Relationship between SAA, CRP, L, SAA/L levels and disease progression
The dynamic changes of SAA, CRP, L, and SAA/L reflected the change of patient condition at 3-5 day-hospitalization. Patients with decreased SAA2, CRP2, SAA2/L2 and elevated L2 were more likely to have improved conditions (table 3) .
To detect if SAA2/L2 is more sensitive in predicting the progression of disease, the authors used ROC curve analysis results at three time points indicated SAA/L was more sensitive in predicting the progression of disease, especially SAA2/L2 at the second time point, with the sensitivity high at 0.933 (Fig 4) .
Relationship between SAA3, CRP3, L3, SAA3/L3 levels and patient outcome at the composite endpoint
The authors performed a multivariate analysis of variance for SAA levels that were measured at three time points. The results showed a significant correlation of SAA dynamics and patient outcome. Specifically, SAA3, CRP3, and SAA3/L3 levels continued to increase whereas L consistently decreased in exacerbating and deceased patients. While, the levels of SAA3, CRP3, and L3 were within normal ranges in recovered patients (table 5) The relationship between the dynamic changes of SAA, CRP, l, SAA / L and clinical outcome at composite endpoint
In patients who were discharged/well recovered, from the first time point at admission to the third time point at composite endpoint, the levels of SAA, CRP, and SAA/L consistently decreased, but L consistently increased. While, in exacerbating and deceased patients, the levels of SAA, CRP, and SAA/L consistently increased, whereas L decreased (table 6) .
To detect if SAA and L dynamic changes are valuable in predicting the patient outcome, the authors used ROC curve analysis to calculate the AUC of the difference of SAA, L, and SAA/L between the first and third time point, with the criteria of patient discharge as negative whereas patient death as positive. The results showed that AUC from high to low were L1-L3>SAA3-SAA1>SAA3/L3-SAA1/L1, with the specific value of 0.925，0.884, and 0.863, respectively( Fig   5) .
The relationship between CT imaging and clinical outcome
The CT imaging features were evaluated and scored as follows: normal (0 points), mild (1 point),
progressive (2 points), and severe (3 points). Of the CT scans performed at admission, 98.5%
(130/132) showed abnormalities, and only two cases were normal. 
The relationship between SAA level and serial CT scan
According to the correlation analysis showed in table 8, the first SAA level at admission was correlated with the dynamic changes of the first, second, and third CT scans. Specifically, for the patients with higher level of SAA1 at admission, the CT classification tended towards severe.
The correlation of the first SAA with the second CT result was higher than that with the first CT result, suggesting the significance of SAA in estimating the progression of disease was higher than CT scan alone (table 8) .
Discussion
COVID-19 is an acute infectious disease caused by a new coronavirus (SARS-CoV-2). The main
initial symptom is mild to moderate fever 3 5 . Some patients may have multiple systematic symptoms such as chills, malaise, respiratory distress, or gastroenterological disorders like nausea/vomiting. In some cases, the disease progresses rapidly and patients develop acute respiratory distress syndrome, septic shock, uncompensated acidosis, and coagulation dysfunction within a few days [5] [6] [7] [8] . The severity and prognosis of COVID-19 are complicated by the diversity of symptoms, imaging manifestations, and the degree of disease progression 8 9 .
Therefore, early diagnosis and appropriate treatment are essential in reducing the morbidity and mortality of COVID-19-infected patients.
Inflammatory factors, such as SAA, CRP, L, PCT, WBC, and PLT are frequently used to predict, diagnose, and evaluate many inflammatory diseases. SAA is a non-specific acute phase protein mainly produced by cytokines IL-1β, IL-6 and TNF-α in liver cells. As a marker of inflammation, its clinical value is obtaining more attention recently [10] [11] [12] . Studies report that patients with severe acute respiratory syndrome had significantly increased level of SAA, suggesting SAA could be used as a biomarker to monitor the progression of respiratory diseases 13 . SAA is able to promote inflammatory response through activating chemokine and inducing chemotaxis even at a very low concentration 14 15 . which boost liver cells to produce SAA 16 17 .
Patients with respiratory virus infection usually have clinical symptoms after 36 to 48 hours of infection, and SAA gradually increases and reaches to peak at 3-4 day post infection. During the phase of recovery, it is reported that SAA level continuously decreased and the decrease rate was faster than that of CRP 18 . CRP is also an acute phase protein produced when infection occurs. SAA/L and elevated L had improved clinical conditions. In addition, the results showed that SAA levels continued to increase in exacerbating and deceased patients, whereas in patients who were discharged and well recovered, SAA fell below 3mg/L. The trend could be described as that patients with progressively decreased SAA are more likely to have a better prognosis than the patients who have continuously high level of SAA, suggesting a significant correlation between SAA dynamic change and prognosis. This phenomenon may be related to the activation of body's inflammation response, which stimulates liver cells to produce a large amount of SAA 20 21 .
CT imaging has been proved to be one of the most significant clinical diagnostic methods for COVID-19. According to the correlation analysis in this study, the first SAA level at admission was correlated with the dynamic changes of the first, second, and third CT scan. Specifically, for the patients with higher level of SAA, the CT classification tended towards severe. The correlation of the first SAA with the second CT result was higher than that with the first CT result, suggesting the value of SAA in estimating the progression of disease, especially when combined with serial CT scans during the course of disease.
This study also found that the ratio of SAA to L was more sensitive than SAA or L used alone, as SAA/L had the highest AUC in ROC analysis, compared with SAA and L. The authors found there was a significant statistical correlation of SAA/L with clinical classification and outcomes when using these critical values as a reference for patient categorization.
Limitations of this study
One limitation of this study lies in it was performed in a single medical facility, lacking the control group design due to the emergent situation of COVID-19 breakout. In the future, the researchers will collaborate with a few medical facilities in the area and design the control group to improve the reliability of the study.
Conclusion
Based on the study results, SAA alone or combined with L (SAA/L) could be used as a significant marker to indicate and track inflammation conditions in COVID-19 infected patients.
SAA and L are sensitive indicators in evaluating the severity and prognosis of COVID-19.
Monitoring dynamic changes of SAA, combined with CT imaging could be a valuable strategy in the diagnosis and treatment of COVID-19. 
